Vital Therapies (VTL) Misses Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts VTL Hot Sheet
Join SI Premium – FREE
Vital Therapies (NASDAQ: VTL) reported Q2 EPS of ($0.63), $0.01 worse than the analyst estimate of ($0.62).
For earnings history and earnings-related data on Vital Therapies (VTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan is worried about further S&P 500 sell-off potential
- Atlantic Union Bankshares (AUB) Misses Q1 EPS by 7c
- Spotify (SPOT) jumps as Q1 print tops estimates on top and bottom lines
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
